The G-C Specific DNA Binding Drug, Mithramycin, Selectively Inhibits Transcription of the C-MYC and C-HA-RAS Genes in Regenerating Liver
- 1 March 1994
- journal article
- research article
- Published by Elsevier BV in The American Journal of the Medical Sciences
- Vol. 307 (3), 167-172
- https://doi.org/10.1097/00000441-199403000-00002
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promotersBiochemistry, 1991
- TGF‐β in Liver Development, Regeneration, and CarcinogenesisaAnnals of the New York Academy of Sciences, 1990
- Mithramycin blocks protein binding and function of the SV40 early promoter.JCI Insight, 1989
- Selective inhibition of c-myc expression by the ribonucleic acid synthesis inhibitor mithramycinAmerican Journal of Obstetrics and Gynecology, 1988
- Rapid Communication: Mithramycin Selectively Inhibits Transcription Of G-C Containing DNAThe American Journal of the Medical Sciences, 1987
- C-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatmentNature, 1984
- Expression of a Cellular Oncogene During Liver RegenerationScience, 1983
- Oncogene Expression in Liver Regeneration and HepatocarcinogenesisHepatology, 1983
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- A general method for isolation of high molecular weight DNA from eukaryotesNucleic Acids Research, 1976